Ari Brettman MD

Ari Brettman MD General Information

Biography

Dr. Ari Brettman is a Senior Managing Director in the BXLS group and a member of the Investment Committee, having joined Blackstone as part of its acquisition of Clarus in December of 2018. He joined Clarus in September 2014. He serves as a Senior Managing Director at Blackstone Life Sciences. He is focused on investments across the firm's portfolio, including collaborations with pharmaceutical and medical technology companies, and BXLS Ownership Investments. Prior to Clarus, he completed a residency in internal medicine and a fellowship in cardiology at Massachusetts General Hospital. He was also an NIH-sponsored post-doctoral fellow at the MGH Center for Systems Biology, where he used electronic medical record-based big data analytics at Partners Healthcare to conduct clinical research and improve disease management. He is a member of the Board of Directors of Anthos Therapeutics and AvenCell. He received his M.D. from Duke University and his AB in History and Science from Harvard College. While a medical student, he was a Sarnoff Cardiovascular Research Foundation Fellow at Stanford University, where he studied angiogenesis.